WE ARE

Sumitomo Dainippon
Pharma Oncology

Dedicated to the promise of purposeful science in oncology

Review Our Pipeline

Scientific persistence

We believe in the power of science—and our people—to make the seemingly impossible possible.

See more

Commitment to discovery

Our external collaborations and investments aim to propel discovery in cancer treatment and complement our areas of concentration.

See more

Our Science

We are committed to pursuing a diverse and purposeful pipeline that investigates drivers of treatment resistance and tumor progression.

Explore more

Featured Clinical Trials

The CanStem 303C clinical trial

Investigating an oncogenic pathways inhibitor in metastatic colorectal cancer

View details
The Wizard 201G clinical trial

Investigating a WT1 cancer vaccine in recurrent or progressive glioblastoma

View details
The Zella 102 clinical trial

Investigating a CDK9
inhibitor in myelodysplastic syndromes

View details

Join Our Team

If you have a passion for making a meaningful difference in the lives of patients and the community, we already have something in common.

Learn more